Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

298
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
298
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

379
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
379
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

424
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
424
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

854
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
854
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.3K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

323
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
323

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.

Aging cell·2026
Same author

RxnBench: A Multimodal Benchmark for Evaluating Large Language Models on Chemical Reaction Understanding from the Scientific Literature.

Journal of chemical information and modeling·2026
Same author

Identification and Evaluation of Conserved Subunit Vaccine Candidates Conferring Cross-Serotype Protection Against <i>Streptococcus suis</i> Serotypes 2, 7, 8, and 9.

Transboundary and emerging diseases·2026
Same author

RIVER delivers multimodal gene-directed regulatory interactions across diverse biological contexts with broad application potentials.

Science China. Life sciences·2026
Same author

NMR-Solver: automated structure elucidation via large-scale spectral matching and physics-guided fragment optimization.

Nature communications·2026
Same author

A dual-functional nanoplatform based on pH-driven self-assembly of pea protein isolate-folic acid conjugate for targeted and stabilized delivery of curcumin.

Food research international (Ottawa, Ont.)·2026
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
Same journal

Structural and Thermodynamic Discrimination between Agonists and Antagonists of Retinoic Acid Receptor γ and the Vitamin D Receptor.

Journal of chemical information and modeling·2026
Same journal

PACEff Builder: An Efficient Platform for Constructing PACE Hybrid-Resolution Models for Molecular Dynamics Simulations of Aqueous Protein, Peptide Assembly, and Membrane Protein Systems.

Journal of chemical information and modeling·2026
Same journal

TransKla: A Local-Global Cross-Attention Based Transformer Approach for Prediction of Lysine Lactylation Sites.

Journal of chemical information and modeling·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 26, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K

一般化可能なデータ駆動型薬物動態学と解釈可能なニューラルODEに向けて

Yaning Cui1, Xiaohong Ji1, Wentao Guo1,2

  • 1DP Technology, Beijing 100089, China.

Journal of chemical information and modeling
|February 25, 2026
PubMed
まとめ
この要約は機械生成です。

Uni-PKは、分子データと個人要因を統合し、薬物濃度時間プロファイルを正確にモデル化する新しいニューラルフレームワークです。このアプローチは、個別化医療のための薬物動態予測を強化し、動物実験を削減します。

キーワード:
薬物動態学ニューラルODE機械学習精密医療創薬

さらに関連する動画

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.5K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

関連する実験動画

Last Updated: Feb 26, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.5K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

科学分野:

  • 薬物動態学と計算生物学
  • 創薬と精密医療
  • ヘルスケアにおける人工知能

背景:

  • 正確な薬物濃度時間(C-t)プロファイルモデリングは、創薬と個別化投与量設定に不可欠です。
  • 従来の薬物動態(PK)モデルは、厳密な仮定と広範なパラメータ化のために、スケーラビリティと適応性に限界があります。
  • 多様な化合物と患者集団を効果的に処理できる高度なモデリングアプローチが必要です。

研究 の 目的:

  • エンドツーエンドの薬物動態モデリングのための統一ニューラルフレームワークであるUni-PKを導入すること。
  • 薬物濃度ダイナミクスの予測のためのスケーラブルで解釈可能なソリューションを開発すること。
  • 個人差を組み込むことにより、個別化された前臨床および臨床アプリケーションを可能にすること。

主な方法:

  • 分子表現とニューラル常微分方程式(NODE)をPK構造内に組み合わせてUni-PKを開発しました。
  • 柔軟なコンテキストエンコーダーを使用して、個別化モデリングのために補助的な共変量(例:種、投与レジメン)を統合しました。
  • 分子および個々の入力から薬物濃度の直接的な動的軌道モデリングを可能にし、データが少ない条件下での学習を容易にしました。

主要な成果:

  • Uni-PKは、様々な投与経路と生理学的状態にわたるラットおよびヒトのデータセットで堅牢なパフォーマンスを示しました。
  • このフレームワークは、確立された薬物動態原理との一貫性を示し、そのメカニズム的根拠を検証しました。
  • データが少なくノイズが多い条件下でも、エンドツーエンドの学習能力を達成し、従来のモデルを上回りました。

結論:

  • Uni-PKは、次世代の薬物動態モデリングのためのスケーラブルで解釈可能で、動物を使用しないソリューションを提供します。
  • 化学構造と個人固有情報の統合は、精密治療を進歩させます。
  • この統一されたニューラルフレームワークは、創薬と個別化投与戦略に大きく影響を与える可能性があります。